PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse

Letters in Drug Design & Discovery

  • h-index: 37
  • Total citations: 16,007
  • Total papers: 2,735
  • Impact factor: 1.0783898305084745

Homepage: http://www.benthamscience.com/lddd

Letters in Drug Design & Discovery

Journal
Visit website →
H-Index = 37
Citations = 16.01K+

Papers

Evidence

Recent papers in Letters in Drug Design & Discovery

  1. The combination gene therapy of HSV-TK/IL-12 inhibits non-small cell lung cancer through the bystander effect associated with Cx43 up-regulation and immune activationLetters in Drug Design & Discovery · Tue,
  2. Evolutionary shifts in representation learning for DTI prediction from sequences to structuresLetters in Drug Design & Discovery · Tue,
  3. Antimicrobial resistance: Emerging challenges, prevention approaches, and the critical need for new drug developmentLetters in Drug Design & Discovery · Tue,
  4. Integrated network pharmacology, transcriptomic analysis, and preliminary cellular validation of Shenqi Dihuang decoction in clear cell renal cell carcinomaLetters in Drug Design & Discovery · Tue,
  5. Integrated network pharmacology and single-cell analysis identify CDK4 and LGALS1 as potential targets for a modified Chaihu Shugan San formula in hepatocellular carcinomaLetters in Drug Design & Discovery · Tue,
  6. Revealing that quercetin targets RPA3 to alleviate chondrocyte injury in knee osteoarthritis based on bioinformatics analysis and molecular dockingLetters in Drug Design & Discovery · Tue,
  7. Discovery and exploratory profiling of a novel BCL-XL PROTACLetters in Drug Design & Discovery · Tue,
  8. Zexieyin formula ameliorates hyperlipidemia by modulating lipid metabolism via the proto-oncogene tyrosine-protein kinase Src signalingLetters in Drug Design & Discovery · Tue,
  9. Computational and experimental investigation of propofol- and remifentanil-associated immunometabolic modulation through amino acid transporters and AMPK–mTOR signaling in macrophagesLetters in Drug Design & Discovery · Tue,
  10. Screening of key genes associated with trigeminal neuralgia and experimental study on topiramate targeting CA2 for anti-neuroinflammatory and anti-oxidative effects in LPS-induced human microgliaLetters in Drug Design & Discovery · Sat,

About Letters in Drug Design & Discovery

Letters in Drug Design & Discovery carries 2,735 indexed papers, 16,007 citations, h-index 37 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Letters in Drug Design & Discovery sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at http://www.benthamscience.com/lddd.

Use the feed below to follow new Letters in Drug Design & Discovery publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 114 words.